315 related articles for article (PubMed ID: 30655556)
1. PD-1/PD-L1 Pathway Modulates Macrophage Susceptibility to Mycobacterium tuberculosis Specific CD8
Suarez GV; Melucci Ganzarain CDC; Vecchione MB; Trifone CA; Marín Franco JL; Genoula M; Moraña EJ; Balboa L; Quiroga MF
Sci Rep; 2019 Jan; 9(1):187. PubMed ID: 30655556
[TBL] [Abstract][Full Text] [Related]
2. PD-1 modulating Mycobacterium tuberculosis-specific polarized effector memory T cells response in tuberculosis pleurisy.
Li J; Jin C; Wu C; Huang J
J Leukoc Biol; 2019 Sep; 106(3):733-747. PubMed ID: 30861206
[TBL] [Abstract][Full Text] [Related]
3. Programmed death-1
Singh A; Mohan A; Dey AB; Mitra DK
Clin Exp Immunol; 2017 Feb; 187(2):269-283. PubMed ID: 27665733
[TBL] [Abstract][Full Text] [Related]
4. BATF Potentially Mediates Negative Regulation of PD-1/PD-Ls Pathway on T Cell Functions in
Liu Q; Ou Q; Shen L; Qiu C; Zhang B; Zhang W; Shao L; Gao Y; Chen ZW
Front Immunol; 2019; 10():2430. PubMed ID: 31681314
[No Abstract] [Full Text] [Related]
5. PD-1 Expression on
Day CL; Abrahams DA; Bunjun R; Stone L; de Kock M; Walzl G; Wilkinson RJ; Burgers WA; Hanekom WA
Front Immunol; 2018; 9():1995. PubMed ID: 30233588
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the PD-1/PD-L1 signaling pathway enhances innate immune response of alveolar macrophages to mycobacterium tuberculosis in mice.
Hu JF; Zhang W; Zuo W; Tan HQ; Bai W
Pulm Pharmacol Ther; 2020 Feb; 60():101842. PubMed ID: 31541762
[TBL] [Abstract][Full Text] [Related]
7. IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients.
de la Barrera S; Aleman M; Musella R; Schierloh P; Pasquinelli V; Garcia V; Abbate E; Sasiain Mdel C
Clin Exp Immunol; 2004 Oct; 138(1):128-38. PubMed ID: 15373915
[TBL] [Abstract][Full Text] [Related]
8. MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection.
Bian Y; Shang S; Siddiqui S; Zhao J; Joosten SA; Ottenhoff THM; Cantor H; Wang CR
PLoS Pathog; 2017 May; 13(5):e1006384. PubMed ID: 28475642
[TBL] [Abstract][Full Text] [Related]
9. PD-1/PD-L pathway inhibits M.tb-specific CD4
Shen L; Gao Y; Liu Y; Zhang B; Liu Q; Wu J; Fan L; Ou Q; Zhang W; Shao L
Sci Rep; 2016 Dec; 6():38362. PubMed ID: 27924827
[TBL] [Abstract][Full Text] [Related]
10. The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8
David P; Megger DA; Kaiser T; Werner T; Liu J; Chen L; Sitek B; Dittmer U; Zelinskyy G
Front Immunol; 2019; 10():54. PubMed ID: 30804928
[TBL] [Abstract][Full Text] [Related]
11. PD-L1 Expression in Monocytes Correlates with Bacterial Burden and Treatment Outcomes in Active Pulmonary Tuberculosis.
Pan SW; Shu CC; Huang JR; Lee CC; Tseng YH; Hung JJ; Hsu PK; Chen NJ; Su WJ; Feng JY; Chen YM
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163542
[TBL] [Abstract][Full Text] [Related]
12. The PD-L1/PD-1 pathway promotes dysfunction, but not "exhaustion", in tumor-responding T cells from pleural effusions in lung cancer patients.
Prado-Garcia H; Romero-Garcia S; Puerto-Aquino A; Rumbo-Nava U
Cancer Immunol Immunother; 2017 Jun; 66(6):765-776. PubMed ID: 28289860
[TBL] [Abstract][Full Text] [Related]
13. Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions.
Garcia-Bates TM; Palma ML; Shen C; Gambotto A; Macatangay BJC; Ferris RL; Rinaldo CR; Mailliard RB
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541848
[TBL] [Abstract][Full Text] [Related]
14. Reactive glia promote development of CD103
Prasad S; Hu S; Sheng WS; Chauhan P; Lokensgard JR
Immun Inflamm Dis; 2018 Jun; 6(2):332-344. PubMed ID: 29602245
[TBL] [Abstract][Full Text] [Related]
15. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis.
Jurado JO; Alvarez IB; Pasquinelli V; Martínez GJ; Quiroga MF; Abbate E; Musella RM; Chuluyan HE; García VE
J Immunol; 2008 Jul; 181(1):116-25. PubMed ID: 18566376
[TBL] [Abstract][Full Text] [Related]
16. [Progress in PD-1/PD-L1, PD-L2 signaling pathway and its role in host anti-tuberculosis immunity].
Yu XW; Zhang JA; Xie JP
Zhonghua Jie He He Hu Xi Za Zhi; 2024 May; 47(5):485-489. PubMed ID: 38706074
[TBL] [Abstract][Full Text] [Related]
17. Morphoproteomics Identifies the Foamy Alveolar Macrophage as an M2 Phenotype with PD-L1 Expression in the Early Lesion of Post-Primary Tuberculosis: Implications for Host Immune Surveillance and Therapy.
Hwang SA; Ali Y; Fedotova E; Hunter RL; Brown RE
Ann Clin Lab Sci; 2020 Jul; 50(4):429-438. PubMed ID: 32826237
[TBL] [Abstract][Full Text] [Related]
18. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes.
Bonecini-Almeida MG; Chitale S; Boutsikakis I; Geng J; Doo H; He S; Ho JL
J Immunol; 1998 May; 160(9):4490-9. PubMed ID: 9574555
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: the relative contribution of classical versus nonclassical HLA restriction.
Lewinsohn DM; Briden AL; Reed SG; Grabstein KH; Alderson MR
J Immunol; 2000 Jul; 165(2):925-30. PubMed ID: 10878367
[TBL] [Abstract][Full Text] [Related]
20. Depletion of PD-1 or PD-L1 did not affect the mortality of mice infected with Mycobacterium avium.
Nakajima M; Matsuyama M; Kawaguchi M; Matsumura S; Kiwamoto T; Matsuno Y; Morishima Y; Yoshida K; Sherpa MT; Yazaki K; Tanaka R; Okiyama N; Muratani M; Ishii Y; Hizawa N
Sci Rep; 2021 Sep; 11(1):18008. PubMed ID: 34504192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
